Who We Are

We have been investors and operators for decades.   Our experiences have led us to the simple belief that the combination of a powerful concept, a talented team, and access to expertise and capital can together bring vision to reality.  As our entrepreneurial partners can attest, we partner closely with them – lending our experience, knowledge and support to achieve their goals.

Learn More


Where We Invest

We invest in the realms we know best:  design and engineering software; Dartmouth College innovations; and the vibrant but underserved technology sector north of Boston.

Learn More


Who We Invest In

Borealis Ventures partners with exceptional entrepreneurs to build great companies from the earliest stages.


Learn More


Avitide, Inc., Secures Series D Financing from Mithril to Expand Affinity Resin Discovery Platform and Resin Manufacturing Operations

September 12th, 2016|

Avitide, Inc., the leader in the discovery, manufacture, and supply of novel affinity purification solutions for the biopharmaceutical industry, closed [...]

Avedro Receives FDA Approval for Photrexa Viscous, Photrexa and the KXL System for Corneal Cross-Linking

April 18th, 2016|

Avedro, Inc., an ophthalmic pharmaceutical and medical device company, has received approval from the U.S. Food and Drug Administration (FDA) [...]

Mutant Yeast Are Cranking Out Pharma’s Next Superdrug

March 10th, 2016|

The offices of Adimab, a biotech company in Lebanon, New Hampshire, smell pleasantly of fresh bread. It’s an olfactory illusion, [...]

See All